Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vascular Surgery

  Free Subscription


Articles published in Am Heart J

Retrieve available abstracts of 107 articles:
HTML format
Text format



Single Articles


    September 2017
  1. GUDNADOTTIR GS, Andersen K, Thrainsdottir IS, James SK, et al
    Gender differences in coronary angiography, subsequent interventions, and outcomes among patients with acute coronary syndromes.
    Am Heart J. 2017;191:65-74.
    PubMed     Text format     Abstract available


  2. WEI J, Mehta PK, Grey E, Garberich RF, et al
    Sex-based differences in quality of care and outcomes in a health system using a standardized STEMI protocol.
    Am Heart J. 2017;191:30-36.
    PubMed     Text format     Abstract available


    August 2017
  3. PROIETTI M, Airaksinen KEJ, Rubboli A, Schlitt A, et al
    Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry.
    Am Heart J. 2017;190:86-93.
    PubMed     Text format     Abstract available


  4. PALMERINI T, Serruys P, Kappetein AP, Genereux P, et al
    Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Am Heart J. 2017;190:54-63.
    PubMed     Text format     Abstract available


    July 2017
  5. FROBERT O, Gotberg M, Angeras O, Jonasson L, et al
    Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial.
    Am Heart J. 2017;189:94-102.
    PubMed     Text format     Abstract available


  6. OHUCHI H, Miyazaki A, Negishi J, Hayama Y, et al
    Hemodynamic determinants of mortality after Fontan operation.
    Am Heart J. 2017;189:9-18.
    PubMed     Text format     Abstract available


  7. ARIOTTI S, van Leeuwen M, Brugaletta S, Leonardi S, et al
    Rationale and design of the Hunting for the off-target propertIes of Ticagrelor on Endothelial function and other Circulating biomarkers in Humans (HI-TECH) trial.
    Am Heart J. 2017;189:128-136.
    PubMed     Text format     Abstract available


    June 2017
  8. BABER U, Sartori S, Aquino M, Kini A, et al
    Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study.
    Am Heart J. 2017;188:73-81.
    PubMed     Text format     Abstract available


  9. WIDMER RJ, Allison TG, Lennon R, Lopez-Jimenez F, et al
    Digital health intervention during cardiac rehabilitation: A randomized controlled trial.
    Am Heart J. 2017;188:65-72.
    PubMed     Text format     Abstract available


  10. GOLDBERG DJ, Zak V, Goldstein BH, Chen S, et al
    Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation.
    Am Heart J. 2017;188:42-52.
    PubMed     Text format     Abstract available


  11. SELKER HP, Udelson JE, Ruthazer R, D'Agostino RB, et al
    Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: A patient-level analysis of randomized clinical trials.
    Am Heart J. 2017;188:18-25.
    PubMed     Text format     Abstract available


  12. ABNOUSI F, Sundaram V, Yong CM, Prats J, et al
    Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial.
    Am Heart J. 2017;188:147-155.
    PubMed     Text format     Abstract available


  13. MELINA G, Angeloni E, Refice S, Monti F, et al
    Clinical SYNTAX score predicts outcomes of patients undergoing coronary artery bypass grafting.
    Am Heart J. 2017;188:118-126.
    PubMed     Text format     Abstract available


  14. KEDHI E, Fabris E, van der Ent M, Kennedy MW, et al
    A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial".
    Am Heart J. 2017;188:11-17.
    PubMed     Text format     Abstract available


    May 2017
  15. FENDER EA, Liang JJ, Sio TT, Stulak JM, et al
    Percutaneous revascularization in patients treated with thoracic radiation for cancer.
    Am Heart J. 2017;187:98-103.
    PubMed     Text format     Abstract available


  16. FINESCHI M, Verna E, Mezzapelle G, Bartolini D, et al
    Assessing MICRO-vascular resistances via IMR to predict outcome in STEMI patients with multivessel disease undergoing primary PCI (AMICRO): Rationale and design of a prospective multicenter clinical trial.
    Am Heart J. 2017;187:37-44.
    PubMed     Text format     Abstract available


  17. BAGAI A, Peterson ED, McCoy LA, Effron MB, et al
    Association of measured platelet reactivity with changes in P2Y12 receptor inhibitor therapy and outcomes after myocardial infarction: Insights into routine clinical practice from the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of
    Am Heart J. 2017;187:19-28.
    PubMed     Text format     Abstract available


  18. LEMMERT ME, Oldroyd K, Barragan P, Lesiak M, et al
    Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicent
    Am Heart J. 2017;187:104-111.
    PubMed     Text format     Abstract available


  19. SCIAHBASI A, Rigattieri S, Sarandrea A, Cera M, et al
    Determinants of operator radiation exposure during percutaneous coronary procedures.
    Am Heart J. 2017;187:10-18.
    PubMed     Text format     Abstract available


    April 2017
  20. SMITS PC, Assaf A, Richardt G, Omerovic E, et al
    Design and rationale of the COMPARE-ACUTE trial: Fractional flow reserve-guided primary multivessel percutaneous coronary intervention to improve guideline indexed actual standard of care for treatment of ST-elevation myocardial infarction in patients
    Am Heart J. 2017;186:21-28.
    PubMed     Text format     Abstract available


  21. EGBE AC, Connolly HM, Khan AR, Niaz T, et al
    Outcomes in adult Fontan patients with atrial tachyarrhythmias.
    Am Heart J. 2017;186:12-20.
    PubMed     Text format     Abstract available


  22. HANNAN EL, Zhong Y, Jacobs AK, Ling FSK, et al
    Incomplete revascularization for percutaneous coronary interventions: Variation among operators, and association with operator and hospital characteristics.
    Am Heart J. 2017;186:118-126.
    PubMed     Text format     Abstract available


    March 2017
  23. BAVISHI C, Sardar P, Chatterjee S, Khan AR, et al
    Intravascular ultrasound-guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: Meta-analysis of randomized trials.
    Am Heart J. 2017;185:26-34.
    PubMed     Text format     Abstract available


  24. LEE H, Koo BK, Park KW, Shin ES, et al
    A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary arte
    Am Heart J. 2017;185:17-25.
    PubMed     Text format     Abstract available


    February 2017
  25. ERNE P, Iglesias JF, Urban P, Eberli FR, et al
    Left bundle-branch block in patients with acute myocardial infarction: Presentation, treatment, and trends in outcome from 1997 to 2016 in routine clinical practice.
    Am Heart J. 2017;184:106-113.
    PubMed     Text format     Abstract available


    January 2017
  26. EGBE AC, Connolly HM, Niaz T, Yogeswaran V, et al
    Prevalence and outcome of thrombotic and embolic complications in adults after Fontan operation.
    Am Heart J. 2017;183:10-17.
    PubMed     Text format     Abstract available


  27. RIMAC G, Fearon WF, De Bruyne B, Ikeno F, et al
    Clinical value of post-percutaneous coronary intervention fractional flow reserve value: A systematic review and meta-analysis.
    Am Heart J. 2017;183:1-9.
    PubMed     Text format     Abstract available


    December 2016
  28. BABER U, Dangas G, Cohen DJ, Gibson CM, et al
    Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study.
    Am Heart J. 2016;182:125-134.
    PubMed     Text format     Abstract available


  29. GRODZINSKY A, Arnold SV, Wang TY, Sharma P, et al
    Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy.
    Am Heart J. 2016;182:111-118.
    PubMed     Text format     Abstract available


  30. HARRISON RW, Radhakrishnan V, Lam PS, Allocco DJ, et al
    Rationale and design of the East-West late lumen loss study: Comparison of late lumen loss between Eastern and Western drug-eluting stent study cohorts.
    Am Heart J. 2016;182:103-110.
    PubMed     Text format     Abstract available


  31. LEE JM, Cho DK, Hahn JY, Song YB, et al
    Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet The
    Am Heart J. 2016;182:1-8.
    PubMed     Text format     Abstract available


    November 2016
  32. YAKSH A, Kik C, Knops P, van Ettinger MJ, et al
    Early, de novo atrial fibrillation after coronary artery bypass grafting: Facts and features.
    Am Heart J. 2016;184:62-70.
    PubMed     Text format     Abstract available


  33. VEROUHIS D, Sorensson P, Gourine A, Henareh L, et al
    Effect of remote ischemic conditioning on infarct size in patients with anterior ST-elevation myocardial infarction.
    Am Heart J. 2016;181:66-73.
    PubMed     Text format     Abstract available


  34. PICCARO DE OLIVEIRA P, Gonzales V, Lopes RD, Schmidt MM, et al
    Serious infections among unselected patients with ST-elevation myocardial infarction treated with contemporary primary percutaneous coronary intervention.
    Am Heart J. 2016;181:52-59.
    PubMed     Text format     Abstract available


  35. DERY JP, Mehta SR, Fisher HN, Zhang X, et al
    Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTud
    Am Heart J. 2016;181:26-34.
    PubMed     Text format     Abstract available


  36. FERRI LA, Morici N, Grosseto D, Tortorella G, et al
    A comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization: Design and rationale of the randomized Elderly-ACS 2 study.
    Am Heart J. 2016;181:101-106.
    PubMed     Text format     Abstract available


    October 2016
  37. AGARWAL SK, Kasula S, Almomani A, Hacioglu Y, et al
    Clinical and angiographic predictors of persistently ischemic fractional flow reserve after percutaneous revascularization.
    Am Heart J. 2016;184:10-16.
    PubMed     Text format     Abstract available


  38. SRA S, Tan MK, Mehta SR, Fisher HN, et al
    Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy.
    Am Heart J. 2016;180:82-9.
    PubMed     Text format     Abstract available


  39. KONTOS MC, Wang TY, Chen AY, Bates ER, et al
    The effect of high-risk ST elevation myocardial infarction transfer patients on risk-adjusted in-hospital mortality: A report from the American Heart Association Mission: Lifeline program.
    Am Heart J. 2016;180:74-81.
    PubMed     Text format     Abstract available


  40. LEMKES JS, Janssens GN, Straaten HM, Elbers PW, et al
    Coronary angiography after cardiac arrest: Rationale and design of the COACT trial.
    Am Heart J. 2016;180:39-45.
    PubMed     Text format     Abstract available


    September 2016
  41. MCNEELY C, Markwell S, Vassileva CM
    Readmission after inpatient percutaneous coronary intervention in the Medicare population from 2000 to 2012.
    Am Heart J. 2016;179:195-203.
    PubMed     Text format     Abstract available


  42. CHANG M, Ahn JM, Kim N, Lee PH, et al
    Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.
    Am Heart J. 2016;179:157-65.
    PubMed     Text format     Abstract available


  43. DE WAHA A, Sandner S, von Scheidt M, Boening A, et al
    A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Inve
    Am Heart J. 2016;179:69-76.
    PubMed     Text format     Abstract available


    August 2016
  44. DECKER C, Garavalia L, Garavalia B, Gialde E, et al
    Understanding physician-level barriers to the use of individualized risk estimates in percutaneous coronary intervention.
    Am Heart J. 2016;178:190-7.
    PubMed     Text format     Abstract available


  45. HARRISON RW, Simon D, Miller AL, de Lemos JA, et al
    Association of hospital myocardial infarction volume with adherence to American College of Cardiology/American Heart Association performance measures: Insights from the National Cardiovascular Data Registry.
    Am Heart J. 2016;178:95-101.
    PubMed     Text format     Abstract available


  46. CAMARO C, Damen SA, Brouwer MA, Kedhi E, et al
    Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial.
    Am Heart J. 2016;178:37-44.
    PubMed     Text format     Abstract available


  47. RAO C, Du J, Li X, Li J, et al
    Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Se
    Am Heart J. 2016;178:9-18.
    PubMed     Text format     Abstract available


    July 2016
  48. DAYOUB EJ, Nallamothu BK
    Geographic access to transcatheter aortic valve replacement relative to other invasive cardiac services: A statewide analysis.
    Am Heart J. 2016;177:163-70.
    PubMed     Text format     Abstract available


  49. TING R, Tejpal A, Finken L, Fisher M, et al
    Repatriation to referral hospital after reperfusion of STEMI patients transferred for primary percutaneous coronary intervention: Insights of a Canadian regional STEMI care system.
    Am Heart J. 2016;177:145-52.
    PubMed     Text format     Abstract available


  50. NDREPEPA G, Iijima R, Kufner S, Braun S, et al
    Association of progression or regression of coronary artery atherosclerosis with long-term prognosis.
    Am Heart J. 2016;177:9-16.
    PubMed     Text format     Abstract available


  51. SHIMADA YJ, Bansilal S, Wiviott SD, Becker RC, et al
    Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
    Am Heart J. 2016;177:1-8.
    PubMed     Text format     Abstract available


    June 2016
  52. GRIMFJARD P, Erlinge D, Koul S, Lagerqvist B, et al
    Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment: A nationwide Swedish registry report.
    Am Heart J. 2016;176:78-82.
    PubMed     Text format     Abstract available


  53. DE LUCA L, Capranzano P, Patti G, Parodi G, et al
    Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations.
    Am Heart J. 2016;176:44-52.
    PubMed     Text format     Abstract available


  54. VAN DER HEIJDEN LC, Kok MM, Danse PW, Schramm AR, et al
    Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial.
    Am Heart J. 2016;176:28-35.
    PubMed     Text format     Abstract available


  55. ANDERSON LL, Dai D, Miller AL, Roe MT, et al
    Percutaneous coronary intervention for older adults who present with syncope and coronary artery disease? Insights from the National Cardiovascular Data Registry.
    Am Heart J. 2016;176:1-9.
    PubMed     Text format     Abstract available


    April 2016
  56. GARGIULO G, Costa F, Ariotti S, Biscaglia S, et al
    Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial.
    Am Heart J. 2016;174:95-102.
    PubMed     Text format     Abstract available


  57. ADAMS GL, Mustapha J, Gray W, Hargus NJ, et al
    The LIBERTY study: Design of a prospective, observational, multicenter trial to evaluate the acute and long-term clinical and economic outcomes of real-world endovascular device interventions in treating peripheral artery disease.
    Am Heart J. 2016;174:14-21.
    PubMed     Text format     Abstract available


  58. KOHL LP, Leimberger JD, Chiswell K, Jones WS, et al
    Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trial.
    Am Heart J. 2016;174:7-13.
    PubMed     Text format     Abstract available


  59. LIKOSKY DS, Zhang M, Paone G, Collins J, et al
    Impact of institutional culture on rates of transfusions during cardiovascular procedures: The Michigan experience.
    Am Heart J. 2016;174:1-6.
    PubMed     Text format     Abstract available


    March 2016
  60. UEDA H, Kido A, Matsuhisa S, Asawa K, et al
    Addition of cilostazol to aspirin therapy for secondary prevention of cardiovascular and cerebrovascular disease in patients undergoing percutaneous coronary intervention: A randomized, open-label trial.
    Am Heart J. 2016;173:134-42.
    PubMed     Text format     Abstract available


  61. LU J, Bagai A, Buller C, Cheema A, et al
    Incidence and characteristics of inappropriate and false-positive cardiac catheterization laboratory activations in a regional primary percutaneous coronary intervention program.
    Am Heart J. 2016;173:126-33.
    PubMed     Text format     Abstract available


  62. ACHARJEE S, Teo KK, Jacobs AK, Hartigan PM, et al
    Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
    Am Heart J. 2016;173:108-17.
    PubMed     Text format     Abstract available


  63. VAVALLE JP, van Diepen S, Clare RM, Hochman JS, et al
    Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes.
    Am Heart J. 2016;173:57-66.
    PubMed     Text format     Abstract available


  64. VASSALLI G, Klersy C, De Servi S, Galatius S, et al
    Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial.
    Am Heart J. 2016;173:1-7.
    PubMed     Text format     Abstract available


    February 2016
  65. THIELE H, Desch S, Piek JJ, Stepinska J, et al
    Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial.
    Am Heart J. 2016;172:160-9.
    PubMed     Text format     Abstract available


  66. SAIKI H, Sugimoto M, Kuwata S, Kurishima C, et al
    Novel mechanisms for cerebral blood flow regulation in patients with congenital heart disease.
    Am Heart J. 2016;172:152-9.
    PubMed     Text format     Abstract available


  67. CALAIS F, Lagerqvist B, Leppert J, James SK, et al
    Thrombus aspiration in patients with large anterior myocardial infarction: A Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia trial substudy.
    Am Heart J. 2016;172:129-34.
    PubMed     Text format     Abstract available


  68. SARA JD, Lennon RJ, Gulati R, Singh M, et al
    Utility of the Framingham Risk Score in predicting secondary events in patients following percutaneous coronary intervention: A time-trend analysis.
    Am Heart J. 2016;172:115-28.
    PubMed     Text format     Abstract available


  69. DONOVAN RJ, Ha J, Sumption KF, Dardik A, et al
    Adjunctive anticoagulation during peripheral vascular intervention.
    Am Heart J. 2016;172:106-14.
    PubMed     Text format     Abstract available


  70. LIU Y, Chen JY, Huo Y, Ge JB, et al
    Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEM
    Am Heart J. 2016;172:88-95.
    PubMed     Text format     Abstract available


  71. DIDIER R, Gaglia MA Jr, Koifman E, Kiramijyan S, et al
    Cerebrovascular accidents after percutaneous coronary interventions from 2002 to 2014: Incidence, outcomes, and associated variables.
    Am Heart J. 2016;172:80-7.
    PubMed     Text format     Abstract available


  72. SEBBEN JC, Pinto Ribeiro DR, Lopes RD, de Winter R, et al
    The role of diabetes mellitus in the composition of coronary thrombi in patients presenting with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Am Heart J. 2016;172:26-33.
    PubMed     Text format     Abstract available


  73. WANG TY, McCoy LA, Bhatt DL, Rao SV, et al
    Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction.
    Am Heart J. 2016;172:9-18.
    PubMed     Text format     Abstract available


    January 2016
  74. EYUBOGLU M
    Preoperative diagnosis and postoperative prognosis in patients undergoing coronary artery bypass graft surgery.
    Am Heart J. 2016;171:e9.
    PubMed     Text format    


  75. JONES WS, Patel MR, Tsai TT, Shetterly SM, et al
    Response to Letter to the Editor regarding "Anatomic runoff score predicts cardiovascular outcomes in patients with lower extremity peripheral artery disease undergoing revascularization".
    Am Heart J. 2016;171:e7.
    PubMed     Text format    


  76. EYUBOGLU M
    Clinical outcomes in patients with lower extremity peripheral artery disease undergoing revascularization.
    Am Heart J. 2016;171:e5.
    PubMed     Text format    


  77. HERTZBERG D, Sartipy U, Holzmann MJ
    Letter in response to "Assessing the association of diabetes mellitus with acute kidney injury after coronary artery bypass grafting" by Fu-Shan Xue et al.
    Am Heart J. 2016;171:e3.
    PubMed     Text format    


  78. BAINEY KR, Norris C, Shavadia J
    Response to: Letter to the Editor regarding the manuscript "Symptomatic graft failure and impact on clinical outcome after coronary artery bypass grafting surgery: Results from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Di
    Am Heart J. 2016;171:e11.
    PubMed     Text format    


  79. XUE FS, Liu GP, Li RP
    Assessing the association of diabetes mellitus with acute kidney injury after coronary artery bypass grafting.
    Am Heart J. 2016;171:e1-2.
    PubMed     Text format    


  80. KIM EK, Choi JH, Song YB, Hahn JY, et al
    A protective role of early collateral blood flow in patients with ST-segment elevation myocardial infarction.
    Am Heart J. 2016;171:56-63.
    PubMed     Text format     Abstract available


  81. WARREN J, Mehran R, Baber U, Xu K, et al
    Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI)
    Am Heart J. 2016;171:40-7.
    PubMed     Text format     Abstract available


  82. SHAH R, Rogers KC, Matin K, Askari R, et al
    An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention.
    Am Heart J. 2016;171:14-24.
    PubMed     Text format     Abstract available


  83. KOLLURI R, Plessa AL, Sanders MC, Singh NK, et al
    A randomized study of the safety and efficacy of fondaparinux versus placebo in the prevention of venous thromboembolism after coronary artery bypass graft surgery.
    Am Heart J. 2016;171:1-6.
    PubMed     Text format     Abstract available


    December 2015
  84. CHANDRASEKHAR J, Mastoris I, Baber U, Sartori S, et al
    Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry.
    Am Heart J. 2015;170:1234-42.
    PubMed     Text format     Abstract available


  85. BOYDEN TF, Joynt KE, McCoy L, Neely ML, et al
    Collaborative quality improvement vs public reporting for percutaneous coronary intervention: A comparison of percutaneous coronary intervention in New York vs Michigan.
    Am Heart J. 2015;170:1227-33.
    PubMed     Text format     Abstract available


  86. IZADI AMOLI A, Bozorgi A, HajHossein Talasaz A, Salehi Omran A, et al
    Efficacy of colchicine versus placebo for the treatment of pericardial effusion after open-heart surgery: A randomized, placebo-controlled trial.
    Am Heart J. 2015;170:1195-201.
    PubMed     Text format     Abstract available


  87. SPENCER FA, Sekercioglu N, Prasad M, Lopes LC, et al
    Culprit vessel versus immediate complete revascularization in patients with ST-segment myocardial infarction-a systematic review.
    Am Heart J. 2015;170:1133-9.
    PubMed     Text format     Abstract available


  88. PRATI F, Romagnoli E, Limbruno U, Pawlowski T, et al
    Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: The COCTAIL II trial.
    Am Heart J. 2015;170:1116-23.
    PubMed     Text format     Abstract available


  89. DASARI TW, Saucedo JF, Krim S, Alkhouli M, et al
    Clinical characteristics and in hospital outcomes of heart transplant recipients with allograft vasculopathy undergoing percutaneous coronary intervention: Insights from the National Cardiovascular Data Registry.
    Am Heart J. 2015;170:1086-91.
    PubMed     Text format     Abstract available


  90. KOHSAKA S, Miyata H, Ueda I, Masoudi FA, et al
    An international comparison of patients undergoing percutaneous coronary intervention: A collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database-Keio interhospital Cardiovascular Studies (JCD-KiCS).
    Am Heart J. 2015;170:1077-85.
    PubMed     Text format     Abstract available


    November 2015
  91. DUDEK D, Dziewierz A, Widimsky P, Bolognese L, et al
    Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myo
    Am Heart J. 2015;170:1025-1032.
    PubMed     Text format     Abstract available


  92. GOTBERG M, Christiansen EH, Gudmundsdottir I, Sandhall L, et al
    Instantaneous Wave-Free Ratio versus Fractional Flow Reserve guided intervention (iFR-SWEDEHEART): Rationale and design of a multicenter, prospective, registry-based randomized clinical trial.
    Am Heart J. 2015;170:945-50.
    PubMed     Text format     Abstract available


  93. RAO SV, Zeymer U, Douglas PS, Al-Khalidi H, et al
    A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial
    Am Heart J. 2015;170:929-37.
    PubMed     Text format     Abstract available


  94. HERTZBERG D, Sartipy U, Holzmann MJ
    Type 1 and type 2 diabetes mellitus and risk of acute kidney injury after coronary artery bypass grafting.
    Am Heart J. 2015;170:895-902.
    PubMed     Text format     Abstract available


  95. CANTOR WJ, Mehta SR, Yuan F, Dzavik V, et al
    Radial versus femoral access for elderly patients with acute coronary syndrome undergoing coronary angiography and intervention: insights from the RIVAL trial.
    Am Heart J. 2015;170:880-6.
    PubMed     Text format     Abstract available


  96. COHEN MG, Matthews R, Maini B, Dixon S, et al
    Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience.
    Am Heart J. 2015;170:872-9.
    PubMed     Text format     Abstract available


  97. CHEN WR, Hu SY, Chen YD, Zhang Y, et al
    Effects of liraglutide on left ventricular function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Am Heart J. 2015;170:845-54.
    PubMed     Text format     Abstract available


    October 2015
  98. CHHATRIWALLA AK, Venkitachalam L, Kennedy KF, Stolker JM, et al
    Relationship between stent type and quality of life after percutaneous coronary intervention for acute myocardial infarction.
    Am Heart J. 2015;170:796-804.
    PubMed     Text format     Abstract available


  99. KURZ DJ, Bernheim AM, Tuller D, Zbinden R, et al
    Improved outcomes of elderly patients treated with drug-eluting versus bare metal stents in large coronary arteries: Results from the BAsel Stent Kosten-Effektivitats Trial PROspective Validation Examination randomized trial.
    Am Heart J. 2015;170:787-795.
    PubMed     Text format     Abstract available


  100. WANG TY, Henry TD, McCoy LA, Berger PB, et al
    Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United States.
    Am Heart J. 2015;170:706-14.
    PubMed     Text format     Abstract available


  101. NICOLAU JC, Bhatt DL, Roe MT, Lokhnygina Y, et al
    Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition t
    Am Heart J. 2015;170:683-694.
    PubMed     Text format     Abstract available


  102. ACHILLI F, Malafronte C, Cesana F, Maggiolini S, et al
    Granulocyte-colony stimulating factor for large anterior ST-elevation myocardial infarction: Rationale and design of the prospective randomized phase III STEM-AMI OUTCOME trial.
    Am Heart J. 2015;170:652-658.
    PubMed     Text format     Abstract available


  103. ZIMMERMANN FM, De Bruyne B, Pijls NH, Desai M, et al
    Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: A comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients wi
    Am Heart J. 2015;170:619-626.
    PubMed     Text format     Abstract available


    September 2015
  104. DUPPEN N, Etnel JR, Spaans L, Takken T, et al
    Does exercise training improve cardiopulmonary fitness and daily physical activity in children and young adults with corrected tetralogy of Fallot or Fontan circulation? A randomized controlled trial.
    Am Heart J. 2015;170:606-14.
    PubMed     Text format     Abstract available


  105. KIM C, Kim BK, Lee SY, Shin DH, et al
    Incidence, clinical presentation, and predictors of early neoatherosclerosis after drug-eluting stent implantation.
    Am Heart J. 2015;170:591-7.
    PubMed     Text format     Abstract available


  106. KERTAI MD, Li YJ, Ji Y, Qi W, et al
    Genome-wide association study of new-onset atrial fibrillation after coronary artery bypass grafting surgery.
    Am Heart J. 2015;170:580-590.
    PubMed     Text format     Abstract available


  107. DAUBERT MA, Massaro J, Liao L, Pershad A, et al
    High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction.
    Am Heart J. 2015;170:550-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: